{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":4,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":4,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f11415678379","filters":{"venue":"Rare Disease and Orphan Drugs Journal"}},"results":[{"id":"W4226226005","doi":"10.20517/rdodj.2022.01","title":"Enhancing the value of clinical networks for rare diseases","year":2022,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Legitimacy; Health care; Knowledge management; Public relations; Diversity (politics); Best practice; Medicine; Political science; Computer science","authors":[{"name":"Matthew Bolz-Johnson","is_ca":false},{"name":"Louise Clément","is_ca":true},{"name":"William A. Gahl","is_ca":false},{"name":"Carmencita D. Padilla","is_ca":false},{"name":"Yukiko Nishumura","is_ca":false},{"name":"Peirong Yang","is_ca":false},{"name":"Lisa Sarfaty","is_ca":false},{"name":"Gareth Baynam","is_ca":false},{"name":"Thomas Kenny","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0097746278647512,"gpt":0.2818339027353585,"spread":0.2720592748706073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004707233,0.0001477673,0.0002162943,0.00003400702,0.0006742442,0.00005132467,0.0002868055,0.00004017197,0.00006944229],"category_scores_gemma":[0.0001881442,0.0001089266,0.0004228957,0.00006276161,0.0001028372,0.000006343096,0.0002492388,0.000159601,3.41281e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009024033,"about_ca_system_score_gemma":0.0003473592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002263898,"about_ca_topic_score_gemma":0.000001435378,"domain_scores_codex":[0.9986174,0.0002143772,0.0004674852,0.000263208,0.0001859713,0.000251535],"domain_scores_gemma":[0.9988953,0.000101682,0.000264076,0.0002535821,0.0001057238,0.0003795727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03571869,0.006186965,0.3802649,0.001275464,0.006436344,0.001227545,0.002272043,0.05611706,0.02344433,0.006782143,0.2937568,0.1865176],"study_design_scores_gemma":[0.01988024,0.004553303,0.3380168,0.0003690522,0.004838197,0.0009678956,0.01733512,0.01498212,0.00523399,0.0111818,0.5794904,0.00315106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707542,0.02581233,0.001557658,0.0003329865,0.0006951509,0.0002884762,0.000525407,0.000005607439,0.00002815338],"genre_scores_gemma":[0.996164,0.001221626,0.00007724707,0.0008302146,0.001202544,0.00004834923,0.0002159338,0.0000258754,0.0002141766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2857335,"threshold_uncertainty_score":0.518581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367019825","doi":"10.20517/rdodj.2023.04","title":"Sustainable approaches for drug repurposing in rare diseases: recommendations from the IRDiRC Task Force","year":2023,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadiana.org","funders":"","keywords":"Repurposing; Drug repositioning; Identification (biology); Medicine; Sustainability; Task (project management); Task force; Drug development; Business; Drug; Pharmacology; Engineering; Political science","authors":[{"name":"Galliano Zanello","is_ca":false},{"name":"Diego Ardigò","is_ca":false},{"name":"Florence Guillot","is_ca":false},{"name":"Anneliene Hechtelt Jonker","is_ca":false},{"name":"Oxana Iliach","is_ca":true},{"name":"Hervé Nabarette","is_ca":false},{"name":"Daniel O’Connor","is_ca":false},{"name":"Virginie Hivert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04927013266708733,"gpt":0.3354894228361923,"spread":0.2862192901691049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079859,0.0001545888,0.0002333122,0.0000820967,0.0008554113,0.0001996304,0.000116549,0.00002920566,0.0001142337],"category_scores_gemma":[0.0005990209,0.0001027375,0.0001510601,0.0003186429,0.00006649233,0.0003863446,0.0001155981,0.0002882487,0.000007218349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007593494,"about_ca_system_score_gemma":0.0001563498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004417389,"about_ca_topic_score_gemma":0.00001013952,"domain_scores_codex":[0.9986917,0.0001402658,0.0002854354,0.0002456922,0.0002122668,0.0004246795],"domain_scores_gemma":[0.9982371,0.0009200721,0.0001222656,0.000164181,0.00008967825,0.0004666641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008064575,0.001064036,0.1192181,0.001302977,0.001607383,0.002721809,0.02318806,0.0001756792,0.00008609577,0.002964229,0.5905741,0.249033],"study_design_scores_gemma":[0.007251749,0.0001119813,0.07068246,0.0007767838,0.002037545,0.00007215053,0.1255431,0.008273127,0.00005233113,0.02650307,0.7581865,0.0005092861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7906239,0.05800974,0.0003549361,0.1467233,0.0005187741,0.002045252,0.0007212737,0.0001369193,0.0008659129],"genre_scores_gemma":[0.9853357,0.007388709,0.0001358434,0.00251169,0.0009121567,0.0001466775,0.000341323,0.00003427168,0.003193614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2485237,"threshold_uncertainty_score":0.6579219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400570519","doi":"10.20517/rdodj.2023.61","title":"Fabry nephropathy: a treatable cause of chronic kidney disease","year":2024,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Globotriaosylceramide; Medicine; Fabry disease; Enzyme replacement therapy; Proteinuria; Albuminuria; Nephropathy; Kidney disease; Alpha-galactosidase; Internal medicine; Podocyte; Cardiomyopathy; Dialysis; Glomerular basement membrane; Kidney; Disease; Heart failure; Pathology; Urology; Endocrinology; Diabetes mellitus","authors":[{"name":"Michael L. West","is_ca":true},{"name":"Laurette Geldenhuys","is_ca":true},{"name":"Daniel G. Bichet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01343904179696902,"gpt":0.2903369501416745,"spread":0.2768979083447055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000208496,0.0002195613,0.0003099228,0.0003117915,0.0001764163,0.0001671132,0.0001292906,0.00005045669,0.001568296],"category_scores_gemma":[0.0002391162,0.0001694703,0.0002476144,0.0003636058,0.000157313,0.0003559516,0.00008773889,0.0003744623,0.0000677276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001986962,"about_ca_system_score_gemma":0.002560889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002437968,"about_ca_topic_score_gemma":0.000001852374,"domain_scores_codex":[0.9981812,0.00008495777,0.0003231471,0.0003241251,0.0006431494,0.0004434042],"domain_scores_gemma":[0.9969355,0.00005396432,0.00005804991,0.0002913055,0.0001558919,0.002505263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01266468,0.00367899,0.1957039,0.01793583,0.003820597,0.111699,0.005062534,0.00004907107,0.007104594,0.002319932,0.3464399,0.293521],"study_design_scores_gemma":[0.04184481,0.004488619,0.2614822,0.02868198,0.01623488,0.00645782,0.00540369,0.05452045,0.004122951,0.01345416,0.559285,0.004023341],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8670782,0.125309,0.0003270765,0.005099413,0.0004060248,0.000531094,0.0004166758,0.0001017919,0.0007307422],"genre_scores_gemma":[0.9906084,0.004571995,0.00002654822,0.0004562751,0.0007628144,0.0000194718,0.00009631762,0.00005227332,0.003405895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2894976,"threshold_uncertainty_score":0.9993444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400098184","doi":"10.20517/rdodj.2024.14","title":"Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy","year":2024,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Fleurimont","funders":"","keywords":"Globotriaosylceramide; Fabry disease; Enzyme replacement therapy; Genetic enhancement; Medicine; Biomarker; Urine; Internal medicine; Alpha-galactosidase; Urology; Disease; Gastroenterology; Oncology; Gene; Biology","authors":[{"name":"Christiane Auray‐Blais","is_ca":false},{"name":"Paméla Lavoie","is_ca":false},{"name":"Tristan Martineau","is_ca":false},{"name":"C. Anthony Rupar","is_ca":false},{"name":"Dwayne L. Barber","is_ca":false},{"name":"Armand Keating","is_ca":false},{"name":"Ronan Foley","is_ca":false},{"name":"Michael L. West","is_ca":false},{"name":"Jeffrey A. Medin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03650465092311914,"gpt":0.3265417238837958,"spread":0.2900370729606767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007583462,0.0002282393,0.0002345696,0.0005299565,0.0001767907,0.0002525745,0.0001057155,0.00006127924,0.0009907923],"category_scores_gemma":[0.0004191731,0.0001818243,0.0001683086,0.0005436408,0.00008278225,0.000469026,0.00005870144,0.0003756694,0.00006461741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002677107,"about_ca_system_score_gemma":0.000715739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000155434,"about_ca_topic_score_gemma":0.000005724343,"domain_scores_codex":[0.9973455,0.0002744728,0.0003651625,0.0004178108,0.001169352,0.0004277168],"domain_scores_gemma":[0.9984292,0.0001016009,0.00006281454,0.0001909079,0.0002935589,0.0009219162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00240266,0.0005776987,0.7624726,0.0001842214,0.000211195,0.001833043,0.0005949821,0.000004584393,0.0004233886,0.000004444458,0.002162792,0.2291283],"study_design_scores_gemma":[0.004400874,0.00009793746,0.9855925,0.0006775348,0.0001880613,0.00002684564,0.0001427591,0.007154024,0.00004094213,0.0003901898,0.001067259,0.0002211176],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9547207,0.04304892,0.00005861032,0.000929856,0.0003553545,0.0006324953,0.00006073726,0.00004214621,0.0001511497],"genre_scores_gemma":[0.9947982,0.00419917,0.00001576644,0.0001958342,0.0002478217,0.00004860813,0.0002624723,0.00004456163,0.0001875627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2289072,"threshold_uncertainty_score":0.9999225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}